NCT06052527View on ClinicalTrials.gov

Covid-19, Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) and Influenza Treatment System With Machine Learning

CompletedOBSERVATIONAL
Enrollment

27

Participants

Timeline

Start Date

June 16, 2023

Primary Completion Date

September 30, 2023

Study Completion Date

October 1, 2023

Conditions
COVID-19Post-COVID-19 SyndromeInfluenza
Interventions
OTHER

Autonomous Treatment System for Covid-19, Post-Acute Sequelae of SARS-CoV-2 Infection and Influenza Based on Machine Learning

A novel treatment recommendation system for Covid-19, Post-Acute Sequelae of SARS-CoV-2 Infection and Influenza, which is based on machine learning

Trial Locations (1)

650000

Sheng'Ai Traditional Medicine Hospital, Kunming

All Listed Sponsors
collaborator

Sheng'ai Traditional Chinese Medicine Hospital

UNKNOWN

lead

Lizora LLC

INDUSTRY